Pharmafile Logo
Pharmafocus logo
Advanced Search

Obama announces acceleration of Precision Medicines Initiative

February 26, 2016
Medical Communications, Research and Development Obama, Precision Medicine, cancer moonshot, genomics

A year after Barack Obama announced the $200 million Precision Medicines Initiative (PMI), the US President yesterday outlined the next …

News
msd

MHRA approves new indication for MSD’s Ezetrol

February 26, 2016
Medical Communications, Research and Development, Sales and Marketing MHRA, MSD, NICE, ezetrol

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new indication for MSD’s Ezetrol (ezetimibe), making it …

News
nhs_sign

NHS England approves Cancer Drugs Fund proposals

February 26, 2016
Medical Communications, Research and Development ABPI, Cancer Drugs Fund, NHS England

NHS England has approved proposed reforms of the Cancer Drugs Fund, following the end of the 12-week consultation period earlier …

News
ema_logo

EMA recommends AZ/Acerta drug for orphan status in three indications

February 25, 2016
Research and Development AstraZeneca, EMA, Orphan Drugs

The European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) has recommended AstraZeneca and Acerta’s acalabrutinib (ACP-196) for designation …

News
medicines_patent_pool2

The Medicines Patent Pool – five years on

February 25, 2016
Research and Development, Sales and Marketing

Introduction The Medicines Patent Pool (MPP) was founded five years ago as a program to improve access to affordable and …

Feature
gilead-sciences

Gilead announces HIV regimen trial results

February 25, 2016
Medical Communications, Research and Development, Sales and Marketing Gilead Sciences

Gilead Sciences has reported 48-week Phase III trial results suggesting fixed-dose Emtriva and tenofovir alafenamide (F/TAF) combinations matched its Truvada …

News
dr_robert_califf_fda

Senate confirms Dr Robert Califf to lead FDA

February 25, 2016
Medical Communications Drug pricing, FDA, Robert Califf

The US Senate has confirmed Dr Robert Califf as Commissioner of the Food and Drugs Administration, in an overwhelming 89-4 …

Appointment
eli_lilly

European Commission approves Lilly’s Portrazza for NSCLC

February 24, 2016
Research and Development Eli Lilly, Portrazza

The European Commission has approved Eli Lilly’s Portrazza (necitumumab), in combination with gemcitabine and cisplatin chemotherapy, as a first-line treatment …

News
talc

J&J fined $72 million in talc cancer case

February 24, 2016
Research and Development, Sales and Marketing Johnson & Johnson

A Missouri jury has ruled that Johnson & Johnson must pay $72 million to the family of an Alabama woman, …

News
janssen_latest_logo_on_sign_closer

Janssen says cabotegravir/rilpivirine combo matches three-drug HIV maintenance therapy

February 24, 2016
Research and Development Janssen, ViiV

Janssen has announced 32-week data from an ongoing phase IIb study of an HIV regimen comprised of its rilpivirine and …

News
eric_kinnman

NeuroVive board selects Erik Kinnman as new CEO

February 23, 2016

Mitochondrial medicine specialist NeuroVive Pharmaceutical’s board of directors has selected Erik Kinnman as the company’s new chief executive, from March …

Appointment
novo_nordisk

Novo Nordisk says Tresiba reduces hypoglycaemia risk vs Lantus

February 23, 2016
Manufacturing and Production, Research and Development Novo Nordisk

Novo Nordisk has announced trial results suggesting that its drug Tresiba (insulin degludec) carries a reduced risk of hypoglycaemia episodes, …

News
howard_schiller_valeant

Valeant likely to restate financial results after Philidore review

February 23, 2016
Manufacturing and Production, Medical Communications, Sales and Marketing Howard Schiller, Philidore, Valeant

Valeant says it is likely to restate its financial results for the last two years, in the wake of the …

News
viiv_healthcare

ViiV completes BMS HIV pipeline purchase

February 23, 2016
Manufacturing and Production, Medical Communications, Research and Development Bristol-Myers Squibb, GSK, HIV, Pfizer, Shionogi, ViiV

ViiV Healthcare has completed its previously-announced acquisition of Bristol-Myers Squibb’s late-stage HIV R&D assets and its portfolio of preclinical and …

News
fda

Califf clears key hurdle to FDA top job

February 23, 2016
Manufacturing and Production, Medical Communications, Research and Development

Dr Robert Califf, President Obama’s nominee to head up the US Food and Drugs Administration as commissioner, has edged a …

News

Europe approves Bayer haemophilia drug

February 22, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Bayer, haemophilia a

Bayer has received approval from the European Commission for its haemophilia A drug Kovaltry (octocog alfa) in patients of all …

News
pharmafocus_march_front_cover

March edition of Pharmafocus live

February 22, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The March 2016 edition of Pharmafocus is now live and available to read here.

News
amgen_ucb

Amgen and UCB announce positive romosozumab results

February 22, 2016
Medical Communications, Research and Development, Sales and Marketing Amgen, Romosozumab, UCB, osteoporosis

Romosozumab development partners Amgen and UCB have announced positive top-line results from a Phase III study of the drug in postmenopausal …

News
sarah_opendi_and_rasha_kelej_at_the_campaigns_launch

Merck launches infertility programme in Uganda

February 22, 2016
Medical Communications, Sales and Marketing Merck Serono

Germany’s Merck has extended its infertility programme ‘Merck More than a Mother’ to Uganda, launching the campaign in a second …

News
sanofi

FDA to decide on Sanofi diabetes combo

February 22, 2016
Research and Development, Sales and Marketing Lantus, Sanofi

Sanofi will be looking to August for a decision on its new type 2 diabetes combo LixiLan (lixisenatide and Lantus), …

News
The Gateway to Local Adoption Series

Latest content

SMC accepts amivantamab and lazertinib for EGFR-positive lung cancer

May 22, 2026

BioDuro and CTI Biotechnology in preclinical drug development partnership

May 21, 2026

Sygnature Discovery appoints Susanne Back as Head of In Vivo Pharmacology

May 21, 2026

NICE recommends sotatercept for pulmonary arterial hypertension

May 20, 2026

Vetter begins construction of new injectable medicines facility

May 20, 2026